Per Kogner
Karolinska Institutet(SE)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Neuroendocrine Tumor Research Advances, Cancer therapeutics and mechanisms, Lung Cancer Research Studies
Most-Cited Works
- → FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.(1995)501 cited
- → The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation(2014)345 cited
- → Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial(2017)339 cited
- → Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification(2010)280 cited
- → High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours(2008)275 cited
- → High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset(2010)246 cited